+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cryptococcosis Treatment Market - Global Forecast 2026-2032- Product Image
Cryptococcosis Treatment Market - Global Forecast 2026-2032- Product Image
New

Cryptococcosis Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5012985
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cryptococcosis treatment market is undergoing significant transformation, shaped by evolving clinical requirements, advances in antifungal therapy, and operational complexity across healthcare systems. Senior leaders are navigating a changing landscape driven by the need for robust supply chains and clinically-effective solutions.

Market Snapshot: Cryptococcosis Treatment Market

The cryptococcosis treatment market expanded from USD 8.24 billion in 2025 to USD 8.71 billion in 2026 and is forecasted to achieve USD 12.50 billion by 2032, registering a CAGR of 6.12%. This growth reflects rising demand among immunocompromised populations, ongoing drug innovation, and a growing focus on streamlined clinical pathways. Key market drivers include the pursuit of new antifungal agents, prioritization of rapid diagnostics, and carrier methods that support flexible care delivery, especially for at-risk patient cohorts.

Scope & Segmentation of the Cryptococcosis Treatment Market

  • Therapeutic Classes: Includes azoles such as fluconazole, posaconazole, and voriconazole, in addition to flucytosine and polyenes encompassing amphotericin B deoxycholate and liposomal amphotericin B. These therapies underpin first-line treatments and serve a variety of patient types across clinical settings.
  • Administration Routes: Encompass intravenous infusions, oral suspensions, and tablets. Each method impacts how treatment can be delivered, influencing the mix between inpatient hospitalization and outpatient or home-based care.
  • Care Settings: Covers hospitals, outpatient clinics, home care environments, and specialist clinics, reflecting differences in patient monitoring, triage, and access to advanced therapies.
  • Distribution Channels: Spans institutional procurement via offline channels alongside online and specialty pharmacy distribution, expanding reach and facilitating targeted supply strategies.
  • Patient Subpopulations: Targets HIV-infected individuals, immunocompetent patients, and transplant recipients. Each group presents unique risks and requires specific treatment protocols and monitoring regimens.
  • Regions: Addresses Americas, Europe, Middle East & Africa, and Asia-Pacific, each bringing unique regulatory challenges, clinical standards, and manufacturing resources.
  • Technologies: Encompasses advances such as rapid diagnostics, liposomal drug delivery, innovations in oral suspensions, and integrated digital monitoring tools to support medication adherence and outcome tracking.

Key Takeaways: Strategic Insights for Senior Leaders

  • Early and accurate diagnosis, coupled with the precise selection of antifungals, directly impacts outcomes for immunocompromised populations and supports clinician decision-making.
  • New oral and liposomal formulations are enabling a shift toward more outpatient and home-based management, prompting manufacturers and distributors to recalibrate their logistics and support infrastructures.
  • Manufacturers are strengthening partnerships with contract manufacturers and specialty distributors to reinforce supply reliability and respond swiftly to clinical demand spikes.
  • Meeting the specific clinical needs of subpopulations like transplant recipients and HIV-infected patients requires tailored protocols, vigilant monitoring, and rigorous management of potential drug interactions.
  • Regional discrepancies in diagnostic capabilities, procurement guidelines, and regulatory oversight present both hurdles and access opportunities, necessitating adaptable strategies across global markets.
  • Healthcare systems and payers increasingly depend on real-world evidence and continuous post-market safety data to inform therapeutic guidelines and drive broader clinical adoption.

Tariff Impact: Navigating Policy-Driven Supply Chain Changes

Recent United States tariff adjustments have added new layers of complexity to the cryptococcosis treatment market’s supply chain. Procurement and sourcing functions are expanding supplier bases, accelerating vetting procedures, and evaluating regional manufacturing to ensure continuity. These changes are prompting manufacturers to pursue vertical integration and longer-term contractual arrangements for essential ingredients, demanding higher regulatory engagement and capital commitment. At the same time, healthcare providers are mitigating risk with strategic stockpiling and upgraded inventory protocols, making proactive policy dialogue central to preempting potential access interruptions.

Methodology & Data Sources

This assessment utilizes structured interviews with clinicians, procurement executives, and supply chain authorities, complemented by expert panel validation and systematic literature review. Each data point is independently verified and corroborated across stakeholders to ensure accuracy and actionable insight.

Why This Report Matters

  • Empowers leadership to identify risks linked to operational or policy change in the cryptococcosis treatment market, supporting forward-looking resource allocation and planning.
  • Offers actionable guidance for aligning care delivery models, procurement operations, and product innovation with shifting evidence requirements and compliance standards.
  • Delivers detailed segmentation, regional analysis, and technology trends to enable informed investment and partnership strategies for market participants.

Conclusion

Optimal cryptococcosis management demands synchronized advances in therapeutic innovation, supply chain resiliency, and policy coordination. Leaders equipped with these insights can proactively address emerging challenges while ensuring continued patient care and operational stability.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cryptococcosis Treatment Market, by Drug Class
8.1. Azoles
8.1.1. Fluconazole
8.1.2. Posaconazole
8.1.3. Voriconazole
8.2. Flucytosine
8.3. Polyenes
8.3.1. Amphotericin B Deoxycholate
8.3.2. Liposomal Amphotericin B
9. Cryptococcosis Treatment Market, by Administration Route
9.1. Intravenous
9.1.1. Central Line
9.1.2. Peripheral
9.2. Oral
9.2.1. Suspension
9.2.2. Tablet
10. Cryptococcosis Treatment Market, by Patient Type
10.1. HIV Infected
10.2. Non-HIV Infected
10.2.1. Immunocompetent
10.2.2. Transplant Patients
11. Cryptococcosis Treatment Market, by End User
11.1. Clinics
11.1.1. Outpatient Clinics
11.1.2. Specialist Clinics
11.2. Home Care
11.3. Hospitals
12. Cryptococcosis Treatment Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Cryptococcosis Treatment Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cryptococcosis Treatment Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cryptococcosis Treatment Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cryptococcosis Treatment Market
17. China Cryptococcosis Treatment Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Amplyx Pharmaceuticals, Inc.
18.6. Astellas Pharma Inc.
18.7. Bausch Health Companies Inc.
18.8. Bristol-Myers Squibb Company
18.9. Cipla Limited
18.10. Dr. Reddy’s Laboratories Ltd.
18.11. F2G Limited
18.12. Flynn Pharma Ltd.
18.13. Gilead Sciences, Inc.
18.14. Glenmark Pharmaceuticals Limited
18.15. Janssen Pharmaceuticals, Inc.
18.16. Lupin Limited
18.17. Merck & Co., Inc.
18.18. Novartis AG
18.19. NuCare Pharmaceuticals, Inc.
18.20. Pfizer Inc.
18.21. Sigmapharm Laboratories LLC
18.22. Sun Pharmaceutical Industries Limited
18.23. Teva Pharmaceutical Industries Ltd.
18.24. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 140. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 141. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 146. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 163. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 164. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 165. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 168. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 170. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 188. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 189. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 190. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 192. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 193. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 195. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 197. ASEAN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 200. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 201. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 202. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 203. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 204. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 205. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 206. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 207. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 209. GCC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 224. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 225. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 226. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 227. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 228. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 229. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 230. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 231. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 233. BRICS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 236. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 237. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 238. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 239. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 240. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 241. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 242. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 243. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 245. G7 CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 248. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 249. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 250. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 251. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 252. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 253. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 254. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 255. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 257. NATO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 271. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 273. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 274. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2032 (USD MILLION)
TABLE 275. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 276. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 277. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 278. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 279. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2032 (USD MILLION)
TABLE 280. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 282. CHINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cryptococcosis Treatment market report include:
  • Amplyx Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F2G Limited
  • Flynn Pharma Ltd.
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Limited
  • Janssen Pharmaceuticals, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • NuCare Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Sigmapharm Laboratories LLC
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.71 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.5 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Cryptococcosis Therapeutics - Global Strategic Business Report - Product Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Cryptococcosis Therapeutics Market Report 2025 - Product Image

Cryptococcosis Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cryptococcosis Market - Global Forecast 2026-2032 - Product Image

Cryptococcosis Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Cryptococcosis Market Report 2025 - Product Image

Cryptococcosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.